ArticleHealth care science2026
Validation of the World Health Organization Disability Assessment Schedule-II for Measuring Women With a History of Potentially Life-Threatening Maternal Conditions at Six Months Postpartum in Tigray, Northern Ethiopia.
Article in Health care science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) is a popular tool for evaluating functioning and disability in a range of population demographics and medical situations. However, very little is known about the WHODAS 2.0's validity and reliability, particularly when dealing with potentially life-threatening maternal conditions (PLTCs). The aim of this study was to evaluate the validity of the WHODAS 2.0 Tigrigna version. Methods: This cross-sectional study was conducted in Tigray, northern Ethiopia, from December 15 to 20, 2023. Following translation and back translation, women who had experienced PLTCs during a recent pregnancy, childbirth, or postpartum period were administered the 36-item WHODAS 2.0 in Tigrigna version 6 months after the childbirth. In total, 121 women with a history of PLTCs participated. Cronbach's α was used to evaluate internal consistency in all six WHODAS 2.0 domains, while Spearman's correlation coefficient was used to evaluate convergent validity. With confirmatory factor analysis, construct validity was also examined. Results: All domain scores of the Tigrigna version of the WHODAS 2.0 indicated excellent internal consistency ( Conclusion: Despite the small sample limitation, the WHODAS 2.0 tool adapted to the Tigrigna version indicated an acceptable reliability and validity and therefore could be applied to women with a history of PLTCs at 6 months postpartum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.